β3 adrenergic receptor antagonist SR59230A exerts beneficial effects on right ventricular performance in monocrotaline-induced pulmonary arterial hypertension. [electronic resource]
- Experimental and therapeutic medicine Jan 2020
- 489-498 p. digital